Doxorubicin plus sorafenib in treatment of advanced hepatocellular carcinoma
- PMID: 21343576
- DOI: 10.1001/jama.2011.159
Doxorubicin plus sorafenib in treatment of advanced hepatocellular carcinoma
Comment on
-
Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.JAMA. 2010 Nov 17;304(19):2154-60. doi: 10.1001/jama.2010.1672. JAMA. 2010. PMID: 21081728 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
